Trending Now
Adverum Biotechnologies Inc. (NASDAQ: ADVM) Receives Orphan Drug Designation For ADVM-062
Adverum Biotechnologies Inc. (NASDAQ: ADVM) has announced that the US FDA has granted ADVM-062 Orphan Drug Designation. ADVM-062 is a proprietary gene therapy candidate...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Veracyte Inc (NASDAQ:VCYT) Presents New Data That Builds A Case For...
Veracyte Inc (NASDAQ:VCYT) recently presented some new data that makes a strong case for the use of nasal swab samples to test for lung...
MAKE IT MODERN
LATEST REVIEWS
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection...
In the ever-evolving landscape of biotechnology, certain milestones mark significant advancements in the fight against some of humanity's most persistent adversaries: cancer...
MAKE IT MODERN
PERFORMANCE TRAINING
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Micro and Macro Tailwinds Converge for KULR
We want to talk about what we believe to be an underappreciated stock right now: KULR Technology Group Inc. (OTCMKTS:KULR).
But first, the context needs...
Inter & Co Inc (NASDAQ:INTR) bull rally may not subside and here’s why
Inter, a pioneering Brazilian company with its multifaceted "super app", has experienced a remarkable upward trajectory in its shares this year, sparking...
Wall Street Reporter Publishes Comments From Pharmadrug Inc (OTCMKTS: LMLLF), Biodesix Inc (NASDAQ: BDSX),...
Wall Street recently published comments from the company CEOs of Pharmadrug Inc (OTCMKTS: LMLLF), Biodesix Inc (NASDAQ: BDSX), Nova Mentis Life Sciences (OTCMKTS: NMLSF),...
REGENXBIO Inc. (NASDAQ:RGNX) Reports $98.9 Million in Q3 2020 Revenue Driven By Zolgensma Milestone...
REGENXBIO Inc. (NASDAQ:RGNX) has announced its financial results and corporate highlights for the three months ended September 2020.
REGENXBIO received $80 Million in milestone payment...
MAKE IT MODERN
